Azitra Inc Share Price
AZTRAzitra Inc Stock Performance
Open $0.20 | Prev. Close $0.18 | Circuit Range N/A |
Day Range $0.20 - $0.20 | Year Range $0.11 - $2.39 | Volume 1,102 |
Average Traded $0.20 |
Azitra Inc Share Price Chart
About Azitra Inc
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease. The company also develops ATR-04, a genetically modified strain of S. epidermidis that is in Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. It has a collaboration with Bayer. The company was incorporated in 2014 and is based in Branford, Connecticut.
Azitra Inc Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
20-May-26 | $0.20 | $0.20 | +0.00% |
20-May-26 | $0.20 | $0.20 | +8.11% |
18-May-26 | $0.19 | $0.18 | +3.93% |
15-May-26 | $0.19 | $0.18 | -6.32% |
14-May-26 | $0.21 | $0.19 | -13.64% |
12-May-26 | $0.23 | $0.22 | -4.35% |
11-May-26 | $0.23 | $0.23 | +1.32% |